Antimicrobial agents and chemotherapy

• 

  Año 2006, Vol. 50, Número 3

  • In Vitro Activity of Novel Rifamycins against Rifamycin-Resistant Staphylococcus aureus

    C. K. Murphy

    págs. 827-834

    

  • Lack of Evidence for In Vivo Transformation of Zidovudine Triphosphate to Stavudine Triphosphate in Human Immunodeficiency Virus-Infected Patients

    M. Melendez

    págs. 835-840

    

  • Pharmacodynamic Evaluation of the Intracellular Activities of Antibiotics against Staphylococcus aureus in a Model of THP-1 Macrophages

    M. Barcia-Macay

    págs. 841-851

    

  • Structural Correlates of Antibacterial and Membrane-Permeabilizing Activities in Acylpolyamines

    R. Balakrishna

    págs. 852-861

    

  • Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 Study

    M. E. Stryjewski

    págs. 862-867

    

  • Effects of Lipid Formulations of Amphotericin B on Activity of Human Monocytes against Aspergillus fumigatus

    M. Simitsopoulou, J. Dotis, M. Dalakiouridou

    págs. 868-873

    

  • Pharmacokinetics of Telbivudine following Oral Administration of Escalating Single and Multiple Doses in Patients with Chronic Hepatitis B Virus Infection: Pharmacodynamic Implications

    D. M. Lloyd, S. G. Lim, X.-J. Zhou

    págs. 874-879

    

  • Molecular Epidemiology of Acquired-Metallo-beta-Lactamase-Producing Bacteria in Poland

    A. Baraniak, J. Fiett

    págs. 880-886

    

  • Interlaboratory Comparison of PCR-Based Methods for Detection of Penicillin G Susceptibility in Neisseria meningitidis

    M. L. Zarantonelli, M.K. Taha

    págs. 887-892

    

  • Effect of Efflux on Telithromycin and Macrolide Susceptibility in Haemophilus influenzae

    T. Bogdanovich

    págs. 893-898

    

  • Preclinical Profile of VX-950, a Potent, Selective, and Orally Bioavailable Inhibitor of Hepatitis C Virus NS3-4A Serine Protease

    S. J. Almquist, R. B. Perni

    págs. 899-909

    

  • Age-Related Effects on Nelfinavir and M8 Pharmacokinetics: a Population Study with 182 Children

    G. Firtion, V. Jullien, S. Urien, D. Hirt

    págs. 910-916

    

  • Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi

    Manuel Cuenca Estrella

    págs. 917-921

    

  • Rate of Elimination of Wolbachia pipientis by Doxycycline In Vitro Increases following Drug Withdrawal

    B. L. Makepeace

    págs. 922-927

    

  • Pharmacokinetic and Safety Evaluation of High-Dose Combinations of Fosamprenavir and Ritonavir

    M. J. Shelton

    págs. 928-934

    

  • Population Pharmacokinetics of Liposomal Amphotericin B in Pediatric Patients with Malignant Diseases

    K. R. Stephen, C. E. Nath, P. J. Shaw, Y. Hong, S. P. Yadav

    págs. 935-942

    

  • Fluoroquinolone Resistance in Invasive Streptococcus pyogenes Isolates Due to Spontaneous Mutation and Horizontal Gene Transfer

    M. W. R. Pletz

    págs. 943-948

    

  • Involvement of Reactive Oxygen Species in the Action of Ciprofloxacin against Escherichia coli

    S. H. Mangoli, M. Goswami

    págs. 949-954

    

  • In Vitro Characterization of the Anti-Hepatitis B Virus Activity and Cross-Resistance Profile of 2',3'-Dideoxy-3'-Fluoroguanosine

    A. C. Jacquard, M.N. Brunelle

    págs. 955-961

    

  • Biochemical and Molecular Characterization of Three New Variants of AmpC beta-Lactamases from Morganella morganii

    P. Power, J. A. Ayala, M. Galleni

    págs. 962-967

    

  • Artesunate Suppositories versus Intramuscular Artemether for Treatment of Severe Malaria in Children in Papua New Guinea

    H. A. Karunajeewa

    págs. 968-974

    

  • Efficacy and Potential for Resistance Selection of Antipseudomonal Treatments in a Mouse Model of Lung Infection by Hypermutable Pseudomonas aeruginosa

    N. Borrell, María Dolores Maciá Romero

    págs. 975-983

    

  • VP35 Knockdown Inhibits Ebola Virus Amplification and Protects against Lethal Infection in Mice

    S. Enterlein, K. L. Warfield

    págs. 984-993

    

  • Pharmacokinetic-Pharmacodynamic Relationships Describing the Efficacy of Oritavancin in Patients with Staphylococcus aureus Bacteremia

    J. A. Passarell, S. M. Bhavnani

    págs. 994-1000

    

  • Staphylococcal Cassette Chromosome mec (SCCmec) Typing of Methicillin-Resistant Staphylococcus aureus Strains Isolated in 11 Asian Countries: a Proposal for a New Nomenclature for SCCmec Elements

    P. Chongtrakool

    págs. 1001-1012

    

  • SCH 503034, a Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease, Suppresses Polyprotein Maturation and Enhances the Antiviral Activity of Alpha Interferon in Replicon Cells

    B. A. Malcolm

    págs. 1013-1020

    

  • Susceptibility of Cryptococcus neoformans Biofilms to Antifungal Agents In Vitro

    A. Casadevall, J. L. Martinez

    págs. 1021-1033

    

  • Potent Antiscrapie Activities of Degenerate Phosphorothioate Oligonucleotides

    D. A. Kocisko

    págs. 1034-1044

    

  • Mefloquine Induces Dose-Related Neurological Effects in a Rat Model

    G. Dow, R. Bauman, D. Caridha, M. Cabezas

    págs. 1045-1053

    

  • Transfer of Vancomycin Resistance Transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the Gut of Gnotobiotic Mice

    A. Launay, P. D. R. Johnson, S. A. Ballard

    págs. 1054-1062